Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for B5950S113 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Laurence W. Lytton
13G/A
Amendment 4
|
19.5% |
8/17/2026
Event 8/13/2026
|
|
| Laurence W. Lytton | 19.5% | ||
| Lytton-Kambara Foundation | 12.1% | ||
| Lytton Laurence W 13G/A Amendment 3 | 9.6% |
8/13/2026
Event 6/30/2026
|
|
| AWM Investment Company, Inc. 13G/A Amendment 2 | 0% |
7/8/2026
Event 6/30/2026
|
|
|
Exact Sciences Corp
13G/A
Amendment 1
|
12.0% |
1/16/2026
Event 1/9/2026
|
|
| Genomic Health, Inc. | 12.0% | ||
| Exact Sciences Corporation | 12.0% | ||
| Lytton Laurence W 13G/A Amendment 2 | 6.4% |
11/14/2025
Event 9/30/2025
|
|
| Lytton Laurence W 13G/A Amendment 1 | 8.4% |
2/13/2025
Event 12/31/2024
|
|
| AWM Investment Company, Inc. 13G/A Amendment 1 | 10.3% |
2/7/2025
Event 1/31/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 32.1 k | $18.8 k |
| 2026 Q2 | 27 | 16.6 M | $6.80 M |
| 2026 Q1 | 52 | 24.7 M | $56.9 M |
| 2025 Q4 | 56 | 24.3 M | $86.8 M |
| 2025 Q3 | 41 | 22.7 M | $106 M |
| 2025 Q2 | 22 | 21.5 M | $47.6 M |
| 2025 Q1 | 22 | 21.2 M | $30.1 M |
| 2024 Q4 | 25 | 22.5 M | $53.2 M |
| 2024 Q3 | 23 | 22.8 M | $47.4 M |
| 2024 Q2 | 11 | 8.95 M | $21.0 M |
| 2024 Q1 | 16 | 9.36 M | $24.2 M |
| 2023 Q4 | 13 | 9.60 M | $37.6 M |